April 7, 2021 – Vancouver, British Columbia, Canada – Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (the “Company” or “Myconic“) is pleased to announce that the Company has appointed Adam Deffett, CFA, as Vice President of Capital Markets & Communications. Mr. Deffett will lead the Company’s internal capital markets initiatives, as well as associated infrastructure and M&A activity with a goal of amplifying its presence across industry and institutional channels.
“Myconic continues to effectively manage its existing investment portfolio, while evaluating accretive clinical consolidation investment opportunities; underpinned by EBITDA and experienced operators,” commented Adam Deffett. “I look forward to working with Myconic’s C-Suite to expand their capital markets strategies and M&A tactics, in accordance with its existing investment policy and in pursuit of providing significant value to our stakeholders.”
Adam Deffett is a senior capital markets professional with over 15 years of experience in the Canadian equity markets. Adam began his career at RBC Capital Markets and has held senior positions in both sales and trading at various Canadian banks and independent dealers, most recently as Managing Director and Head of Institutional Sales at Laurentian Bank. He has extensive experience in capital raising, shareholder communication and capital markets strategy. Adam also has experience in regulated industries, advising several companies in the cannabis sector before joining a publicly listed company as Senior VP, Corporate Development. Adam graduated with a Bachelor of Commerce degree from the University of Calgary and is a CFA Charterholder.
Myconic Capital Corp is an investment issuer with a diversified portfolio that is focused on emerging companies active in the high-tech, real estate, cannabis, mining and health & wellness sectors.
On behalf of:
MYCONIC CAPITAL CORP.
CEO and Director
For further information, please contact:
The Canadian Securities Exchange (the “CSE”) has not reviewed and does not accept responsibility for the accuracy or adequacy of this release.
Notice Regarding Forward Looking Information:
This news release contains forward-looking statements including statements regarding any of the Myconic holdings or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business, and future prospects of the Company.
The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.